Doximity/$DOCS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Doximity
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
Ticker
$DOCS
Sector
Primary listing
NYSE
Employees
830
Headquarters
Website
Doximity Metrics
BasicAdvanced
$13B
59.31
$1.17
1.36
-
Price and volume
Market cap
$13B
Beta
1.36
52-week high
$85.21
52-week low
$35.32
Average daily volume
1.6M
Financial strength
Current ratio
6.468
Quick ratio
6.202
Long term debt to equity
0.943
Total debt to equity
1.155
Profitability
EBITDA (TTM)
243.905
Gross margin (TTM)
90.14%
Net profit margin (TTM)
39.88%
Operating margin (TTM)
40.57%
Effective tax rate (TTM)
14.36%
Revenue per employee (TTM)
$710,000
Management effectiveness
Return on assets (TTM)
13.13%
Return on equity (TTM)
24.25%
Valuation
Price to earnings (TTM)
59.306
Price to revenue (TTM)
22.042
Price to book
12.67
Price to tangible book (TTM)
13.89
Price to free cash flow (TTM)
45.232
Free cash flow yield (TTM)
2.21%
Free cash flow per share (TTM)
1.533
Growth
Revenue change (TTM)
19.45%
Earnings per share change (TTM)
45.79%
3-year revenue growth (CAGR)
17.71%
3-year earnings per share growth (CAGR)
19.69%
What the Analysts think about Doximity
Analyst ratings (Buy, Hold, Sell) for Doximity stock.
Bulls say / Bears say
Doximity’s Q3 FY2025 revenue rose 25% YoY to $168.6 M, and adjusted EPS of $0.45 topped the $0.34 consensus estimate, leading management to raise full-year FY2025 revenue guidance to $564.6 M–$565.6 M (CNBC)
Engagement levels reached new highs with over 610,000 unique providers using Doximity’s clinical workflow tools, and AI-related activity jumped 60% QoQ, signaling strong adoption of the platform (CNBC)
In Q1 FY2026, Doximity reported sales of $145.9 M, beating the $139.5 M consensus, and raised its FY2026 sales forecast to $628 M–$636 M, pointing to sustained demand and momentum (Reuters)
Despite strong Q4 FY2025 results, Doximity’s cautious Q1 FY2026 revenue guidance ($139 M–$140 M) and full-year FY2026 forecast ($619 M–$631 M) sparked a 16% drop in the stock as investors grew concerned (Barron’s)
Management warned of macroeconomic and policy headwinds, including possible U.S. drug tariffs and pricing reforms, which could prompt pharmaceutical advertisers to cut spending and hurt revenue growth (Barron’s)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.
Doximity Financial Performance
Revenues and expenses
Doximity Earnings Performance
Company profitability
Doximity News
AllArticlesVideos
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
Business Wire2 weeks ago
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Benzinga1 month ago
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
CNBC1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Doximity stock?
Doximity (DOCS) has a market cap of $13B as of September 08, 2025.
What is the P/E ratio for Doximity stock?
The price to earnings (P/E) ratio for Doximity (DOCS) stock is 59.31 as of September 08, 2025.
Does Doximity stock pay dividends?
No, Doximity (DOCS) stock does not pay dividends to its shareholders as of September 08, 2025.
When is the next Doximity dividend payment date?
Doximity (DOCS) stock does not pay dividends to its shareholders.
What is the beta indicator for Doximity?
Doximity (DOCS) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.